Xia Xu

4.9k total citations
122 papers, 3.7k citations indexed

About

Xia Xu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xia Xu has authored 122 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Molecular Biology, 34 papers in Oncology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xia Xu's work include Ovarian cancer diagnosis and treatment (14 papers), Cancer Cells and Metastasis (8 papers) and PARP inhibition in cancer therapy (8 papers). Xia Xu is often cited by papers focused on Ovarian cancer diagnosis and treatment (14 papers), Cancer Cells and Metastasis (8 papers) and PARP inhibition in cancer therapy (8 papers). Xia Xu collaborates with scholars based in China, United States and Canada. Xia Xu's co-authors include Jihui Jia, Zhifang Liu, Mark W. Onaitis, Brigid L.M. Hogan, Yun Lu, Christopher R. Futtner, Jason R. Rock, Xiaoxiang Chen, Cunying Ma and Fenghua Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Xia Xu

116 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xia Xu China 37 2.0k 1.0k 859 511 404 122 3.7k
Alexandru Irimie Romania 29 2.1k 1.0× 1.2k 1.2× 755 0.9× 365 0.7× 214 0.5× 130 3.8k
Wei Zhao China 33 2.5k 1.2× 1.0k 1.0× 1.3k 1.5× 416 0.8× 280 0.7× 130 3.8k
Alexander T.H. Wu Taiwan 40 2.6k 1.3× 1.1k 1.1× 1.1k 1.3× 684 1.3× 529 1.3× 170 5.1k
Yun‐Yong Park South Korea 34 2.2k 1.1× 827 0.8× 844 1.0× 388 0.8× 425 1.1× 71 3.5k
Lin Zhao China 38 2.6k 1.3× 1.6k 1.5× 926 1.1× 579 1.1× 251 0.6× 148 4.3k
Si Sun China 28 1.4k 0.7× 737 0.7× 857 1.0× 565 1.1× 214 0.5× 147 2.9k
Manoj Garg India 39 2.4k 1.2× 990 1.0× 668 0.8× 338 0.7× 180 0.4× 100 3.9k
Gang Song China 29 2.4k 1.2× 845 0.8× 755 0.9× 260 0.5× 291 0.7× 71 4.0k
Chunhong Yan United States 38 3.0k 1.5× 1.4k 1.3× 1.1k 1.3× 791 1.5× 219 0.5× 106 4.8k
Ming Zhao United States 42 3.1k 1.5× 567 0.5× 1.4k 1.6× 615 1.2× 193 0.5× 133 5.3k

Countries citing papers authored by Xia Xu

Since Specialization
Citations

This map shows the geographic impact of Xia Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xia Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xia Xu more than expected).

Fields of papers citing papers by Xia Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xia Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xia Xu. The network helps show where Xia Xu may publish in the future.

Co-authorship network of co-authors of Xia Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xia Xu. A scholar is included among the top collaborators of Xia Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xia Xu. Xia Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Zhuo, Xia Xu, Wei Ren, et al.. (2025). Glymphatic dysfunction in relapsing-remitting multiple sclerosis and its association with brain structural damage and cognitive impairment. Multiple Sclerosis and Related Disorders. 100. 106531–106531.
2.
Chen, Jiahui, Wenwen Guo, Qian Zhao, et al.. (2025). TCGA molecular subtypes in endometriosis-associated ovarian cancer: a systematic review and meta-analysis. Annals of Medicine. 57(1). 2583543–2583543.
3.
Zhu, Mengyue, Xia Xu, Ying Cui, et al.. (2024). Clinical features and prognostic factors of cardiorenal anemia syndrome in China: a retrospective single-center study. BMC Cardiovascular Disorders. 24(1). 761–761.
4.
Xu, Xia, et al.. (2024). An Innovation Management Approach for Electric Vertical Take-Off and Landing. Sustainability. 16(16). 7135–7135. 2 indexed citations
5.
Xu, Xia, et al.. (2023). Advances in mitophagy and mitochondrial apoptosis pathway-related drugs in glioblastoma treatment. Frontiers in Pharmacology. 14. 1211719–1211719. 17 indexed citations
6.
Xu, Xia, Jacob P. Hoj, Rishi R. Rampersad, et al.. (2023). Activation of KrasG12D in Subset of Alveolar Type II Cells Enhances Cellular Plasticity in Lung Adenocarcinoma. Cancer Research Communications. 3(11). 2400–2411.
7.
Wang, Yajiao, Shuqing Shi, Xia Xu, et al.. (2023). SGLT2 inhibitors in the treatment of type 2 cardiorenal syndrome: Focus on renal tubules. SHILAP Revista de lepidopterología. 2. 1109321–1109321. 5 indexed citations
8.
Xu, Xia & Xufeng Yao. (2022). Evaluation of Preprocessing for Functional Magnetic Resonance Imaging Brain Networks. 307–310. 1 indexed citations
9.
Shi, Shuqing, Bingxuan Zhang, Yumeng Li, et al.. (2022). Mitochondrial Dysfunction: An Emerging Link in the Pathophysiology of Cardiorenal Syndrome. Frontiers in Cardiovascular Medicine. 9. 837270–837270. 15 indexed citations
10.
Ma, Cunying, Dandan Wang, Xia Xu, et al.. (2022). Pseudophosphatase STYX is induced by Helicobacter pylori and promotes gastric cancer progression by inhibiting FBXO31 function. Cell Death and Disease. 13(3). 268–268. 4 indexed citations
11.
Li, Haijun, Liwei Cui, Shuang Dou, et al.. (2021). Ginsenoside Rb3 Alleviates CSE-Induced TROP2 Upregulation Through p38 MAPK and NF-κB Pathways in Basal Cells. American Journal of Respiratory Cell and Molecular Biology. 64(6). 747–759. 14 indexed citations
12.
Choi, Wonshik, Xia Xu, Susan Goruk, et al.. (2021). FABP7 Facilitates Uptake of Docosahexaenoic Acid in Glioblastoma Neural Stem-like Cells. Nutrients. 13(8). 2664–2664. 13 indexed citations
13.
Lü, Juan, Qihui Liu, Fan Wang, et al.. (2018). Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK/AKT pathway in nasopharyngeal carcinoma. Journal of Experimental & Clinical Cancer Research. 37(1). 147–147. 176 indexed citations
14.
Xiao, Lin, Dae Joong Kim, James M. Dunleavey, et al.. (2015). Tumor Endothelial Cells with Distinct Patterns of TGFβ-Driven Endothelial-to-Mesenchymal Transition. Cancer Research. 75(7). 1244–1254. 64 indexed citations
15.
Liu, Jiao, Chunyan Wang, Xia Xu, et al.. (2015). Chronopharmacokinetics of Erlotinib and Circadian Rhythms of Related Metabolic Enzymes in Lewis Tumor-Bearing Mice. European Journal of Drug Metabolism and Pharmacokinetics. 41(5). 627–635. 13 indexed citations
16.
Qian, Yingying, Shoujie Chai, Zuyu Liang, et al.. (2014). KIF5B-RET fusion kinase promotes cell growth by multilevel activation of STAT3 in lung cancer. Molecular Cancer. 13(1). 176–176. 47 indexed citations
17.
Zhao, Li, Wenjuan Li, Zhifang Liu, et al.. (2013). JMJD2B Promotes Epithelial–Mesenchymal Transition by Cooperating with β-Catenin and Enhances Gastric Cancer Metastasis. Clinical Cancer Research. 19(23). 6419–6429. 92 indexed citations
18.
Liu, Zhongbo, Xia Xu, Xuesen Li, et al.. (2013). KAVA Chalcone, Flavokawain A, Inhibits Urothelial Tumorigenesis in the UPII-SV40T Transgenic Mouse Model. Cancer Prevention Research. 6(12). 1365–1375. 30 indexed citations
19.
Ylikallio, Emil, Jennifer L. Page, Xia Xu, et al.. (2010). Ribonucleotide reductase is not limiting for mitochondrial DNA copy number in mice. Nucleic Acids Research. 38(22). 8208–8218. 25 indexed citations
20.
Xu, Xia, Jennifer L. Page, Jennifer A. Surtees, et al.. (2008). Broad Overexpression of Ribonucleotide Reductase Genes in Mice Specifically Induces Lung Neoplasms. Cancer Research. 68(8). 2652–2660. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexandru Irimie Breakdown of academic impact, for papers by Wei Zhao Breakdown of academic impact, for papers by Alexander T.H. Wu Breakdown of academic impact, for papers by Yun‐Yong Park Breakdown of academic impact, for papers by Lin Zhao Breakdown of academic impact, for papers by Si Sun Breakdown of academic impact, for papers by Manoj Garg Breakdown of academic impact, for papers by Gang Song Breakdown of academic impact, for papers by Chunhong Yan Breakdown of academic impact, for papers by Ming Zhao
Rankless by CCL
2026